TheProfitWatch

KROS - Keros Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
15.63 -0.9 (-5.76%) --- --- 0.32 (2.19%) -0.63 (-4.03%) -0.52 (-3.47%) 0.33 (2.29%) 0.33 (2.29%)

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.76
Diluted EPS:
-0.76
Basic P/E:
-19.3816
Diluted P/E:
-19.3816
RSI(14) 1m:
100.0
VWAP:
14.73
RVol:

Events

Period Kind Movement Occurred At

Related News